Concepedia

Chenglong Liu

CL

9

Publications

635

Citations

9

H-Index

2019

Active since

Affiliations

Fudan University(Current)

Chinese Academy of Sciences

Shanghai Institute of Materia Medica

University of Chinese Academy of Sciences

Shanghai Institutes for Biological Sciences

Chenglong Liu is an author at Fudan University specializing in cell biology, medicine, and cancer cell biology.

ORCID

Top concepts

Publications per year

2019–2023

9

Publications

9

Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases

Yunbin Zhang, Jingjing Song, Zhongwei Zhao et al. · Cancer Letters · 2019 · 239 citations

, , +11

IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment

Bo Hu, Mincheng Yu, Xiaolu Ma et al. · Cancer Discovery · 2022 · 192 citations

Targeting Wnt/β-Catenin Pathway for Drug Therapy

Chenglong Liu, Kohichi Takada, Di Zhu · Medicine in Drug Discovery · 2020 · 49 citations · Full text

, , +16

RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers

Li Xia, Enming Tian, Mingcheng Yu et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 39 citations · Full text

BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer

Mei Feng, Zhongen Wu, Yan Zhou et al. · Signal Transduction and Targeted Therapy · 2021 · 38 citations · Full text

Rows per page

1–5 of 9